Rheumalef<sup>®</sup> (leflunomide)

  • Jacky van Schoor

Abstract

Rheumalef® is indicated for the treatment of adult patients with active rheumatoid arthritis (RA) as a ‘disease-modifying antirheumatic drug’ (DMARD) and to improve physical function.1
Section
New Product Focus